Larimar Therapeutics Inc (LRMR)

Schlusskurs vom Vortag:

$7.86

Offen:

$7.96

24-Stunden-Volumen:

361.84K

Marktkapitalisierung:

$454.26M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-36.95M

KGV:

-7.7391

EPS:

-0.92

Netto-Cashflow:

$-33.46M

1W Leistung:

-8.31%

1M Leistung:

+4.09%

6M Leistung:

+190.61%

1J Leistung:

+39.06%

1-Tages-Spanne:

$7.08

$7.96

52-Wochen-Spanne:

$2.18

$13.68

Larimar Therapeutics Inc Stock (LRMR) Company Profile

Firmenname

Larimar Therapeutics Inc

Sektor

Healthcare (1212)

Branche

Biotechnology (699)

Telefon

844 511 9056

Adresse

Three Bala Plaza East, Suite 506, Bala Cynwyd, PA

Mitarbeiter

16

Twitter

Nächster Verdiensttermin

2024-05-29

Neueste SEC-Einreichungen

LRMR's Discussions on Twitter

Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten

Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

GlobeNewswire Inc.

Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia

GlobeNewswire Inc.

Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

GlobeNewswire Inc.

Over $37M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Benzinga

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire Inc.

Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga

Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)

Larimar Therapeutics Inc (LRMR) Nettogewinn 2024

Larimar Therapeutics Inc (LRMR) Free Cashflow 2024

Larimar Therapeutics Inc (LRMR) Gewinn je Aktie 2024

Larimar Therapeutics Inc-Aktie (LRMR) Insiderhandel